compound glp 1 vs wegovy Compounded Semaglutide Wegovy: A Practical Editorial Comparison – PlexusDx Novo Nordisk Drops Hims &
Description
See if you may qualify GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) reduce appetite, slow digestion, and support blood sugar regulation

doi: 10.1177/2042018821997320 [DOI] [PMC free article] [PubMed] [Google Scholar] 33.Nauck MA, Quast DR, Wefers J, Meier JJ

Andreini C, Bertini I, Cavallaro G, Holliday GL, Thornton JM

B.PallejaA.WismannP.FabriciusK.RigboltK.et al (2019)

After a 36-week lead-in period with tirzepatide treatment, participants who continued on the compound for an additional 52 weeks achieved 25.8% total weight loss
That changed when the SURMOUNT-5 trial compared tirzepatide (the active ingredient in Zepbound) and semaglutide directly
